UBS Group
INVA icon

UBS Group’s Innoviva INVA Stock Holding History

UBS Group’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500,000
Closed -$6.99M – 8198
2020
Q2 		$6.99M Sell
500,000
-90,000
-15% -$1.22M ﹤0.01% 1791
2020
Q1 		$6.94M Buy
+590,000
New +$7.8M ﹤0.01% 1663

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

UBS Group's INVA Position: Q2 2026 in Review

UBS Group increased its Innoviva (INVA) stake by 24% in Q2 2026, buying an estimated $2.44M and bringing the position to 543,791 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

UBS Group first reported a position in INVA in Q4 2014 and has held it in 47 quarters since. The position peaked at $17M in Q2 2018. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • UBS Group held 543,791 shares of Innoviva worth $12.3M as of Q2 2026.
  • UBS Group bought 106,698 Innoviva shares in Q2 2026, an estimated $2.44M.
  • Innoviva made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3212 holding.
  • UBS Group first reported a position in Innoviva in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Innoviva position peaked at $17M in Q2 2018.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.